Launched in 1999 in Copenhagen, Denmark, we are a twin-detailed, international biotechnology enterprise specializing from the generation and enhancement of differentiated antibody therapeutics for your cure of most cancers. We're led by a highly skilled Worldwide management workforce. Our proprietary product pipeline and next-technology antibody sy